Pulmonary sarcoidosis developing during infliximab therapy.
O'Shea
Finbar D
FD
Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
Marras
Theodore K
TK
Inman
Robert D
RD
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001168:Arthritis / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D017565:Sarcoidosis, Pulmonary / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D014057:Tomography, X-Ray Computed; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab